What Is CJC-1295 DAC?

CJC-1295 with DAC adds a Drug Affinity Complex to the modified GRF backbone — a chemical hook that binds the peptide to albumin in the bloodstream, extending its half-life from minutes to roughly 6-8 days. One weekly injection keeps GHRH signaling continuously elevated.

The trade-off is physiological: instead of amplified pulses, you get a sustained moderate elevation of GH and IGF-1 — the 'GH bleed.' Convenient, potent on IGF-1 bloodwork, and debated among purists who prefer mimicking the body's pulsatile pattern.

What is CJC-1295 DAC studied for?

Side effects & safety

Same GHRH-family effects (flushing, water retention) plus bleed-specific ones: more consistent IGF-1 elevation means glucose drift and swelling are more likely than with pulsatile protocols. Periodic bloodwork is the responsible companion.

Legal & approval status

Research chemical; no approvals. WADA-banned.

Typical dosing at a glance

Commonly reported protocols use 1 mg–2 mg, 1–2x weekly, via subcutaneous injection. For the mixing math — how much bacteriostatic water, exact syringe units, doses per vial — see the CJC-1295 DAC reconstitution calculator →

Related peptides

What is Ipamorelin?What is CJC-1295 (no DAC)?What is Sermorelin?What is Tesamorelin?What is Hexarelin?

Educational overview based on published research and commonly reported community protocols — not medical advice, and not an endorsement of any compound. Consult a licensed healthcare provider.